Ovarian Cancer: Memphis
SurvivorNet has collaborated with patients and physicians to provide women in Memphis, Tennessee, area with helpful information and support during their ovarian cancer journey. We hope these resources make it easier to connect with people in your neighborhood who can help.
Taking Control - A Memphis Survivor Shares Her Story
Most women with ovarian cancer will have chemotherapy at some point in their treatment, and many of them will face the inevitable loss of their hair that results from this therapy. For ovarian cancer survivor, Edie Pursifull, watching her once long blonde hair fall out was "devastating." "I was just crying," sh... Read More
- For many women, surgery is the first treatment for ovarian cancer
- Ovarian cancer surgery is considered a major operation and it can be complex, depending on the extent of the disease
- Recovery time depends on the extent of the procedure
Ovarian Cancer Surgery Guidance for the Memphis Community
- For many women, surgery is the first treatment for ovarian cancer
- Ovarian cancer surgery is considered a major operation and it can be complex, depending on the extent of the disease
- Recovery time depends on the extent of the procedure
- Chemotherapy for ovarian cancer usually involves two drugs carboplatin and paclitaxel
- Sometimes, women with ovarian cancer are given chemo before surgery in an attempt to shrink the tumor
- Chemo is usually given for six cycles one every three weeks
Chemotherapy for Ovarian Cancer
- Chemotherapy for ovarian cancer usually involves two drugs – carboplatin and paclitaxel
- Sometimes, women with ovarian cancer are given chemo before surgery in an attempt to shrink the tumor
- Chemo is usually given for six cycles – one every three weeks
- About 15% of ovarian cancers are linked to genetic mutations
- The most common genetic cause of ovarian cancer is a mutation in the BRCA1 or BRCA2 gene
- Genetic mutations may make a woman’s cancer more responsive to certain types of treatment
What Role Do Genetics Play?
- About 15% of ovarian cancers are linked to genetic mutations
- The most common genetic cause of ovarian cancer is a mutation in the BRCA1 or BRCA2 gene
- Genetic mutations may make a woman’s cancer more responsive to certain types of treatment
- PARP inhibitors help stop the growth of ovarian cancer
- This relatively new class of drugs is now approved for use as part of initial treatment and recurrence
- Most women tolerate PARP inhibitors well, and side effects can typically be managed
Understanding PARP Inhibitors as a Treatment Option
- PARP inhibitors help stop the growth of ovarian cancer
- This relatively new class of drugs is now approved for use as part of initial treatment and recurrence
- Most women tolerate PARP inhibitors well, and side effects can typically be managed
Treating Ovarian Cancer During the Pandemic
The COVID-19 pandemic has changed the way people with cancer are receiving medical care. People with ovarian cancer, who may have a weakened immune system, are particularly vulnerable to infection. Understandably, they may be avoiding visits to a doctor or hospital out of concerns about the risks of exposure. In order... Read More
Learning to Cope with Ovarian Cancer
The goal of palliative care is to help alleviate a patient's symptoms to improve their quality of lifewhether that's during or after cancer treatment. Palliative care is often mistaken for hospice care, but they are actually two different things. Hospice care is for patients who are no longer receiving treatmen... Read More
Living With Side Effects - A Memphis Ovarian Cancer Survivor's Story
When menopause happens naturally, it's a gradual process in which estrogen production slows over time. By contrast, ovarian cancer surgery can thrust a woman into menopause within a day or two. The suddenness of her transition to menopause caught Araceli Rubi off guard. Though her doctor had warned her that she would... Read More